Abstract:Introduction: Differentiated thyroid carcinoma (DTC) is the most common pathological type of thyroid carcinoma, which includes papillary and follicular subtypes. DTC is usually indolent, characterized by good prognosis, and long-term survival. Total thyroidectomy is the mainstay of treatment in DTC which is followed by diagnostic whole body 131I (WBI) scan. Like other primary malignancies of the head and neck, DTC follows a consistent pattern of spread in the cervical LNs. The central compartment, level VI and VII, is the first sentinel node followed by spread to the lateral compartments levels II-V, followed by the contralateral side. Inspite of nodal involvement, DTC usually have a favourable outcome. Presence of extrapulmonary distant metastases could predict a poor prognosis for high-dose 131I therapy. However, distant metastasis occurs often as a grave event and mortality rates vary depending on metastatic sites. Aim and objectives: A range of rare 131I concentrating DTC deposits in sella, orbit, choroid, skeletal muscles, liver, skin, costochondral soft tissue, pancreas and kidney, and a few benign 131I concentrating sites are being depicted. Materials and methods: Metastatic sites from DTC can be easily identified by performing a whole body 131I (WBI) scan along with a stimulated thyroglobulin (Tg) estimation (TSH >30 uIU/ml). Apart from thyroid and thyroid-related diseases, certain benign non-thyroidal pathologies can concentrate radioiodine (131I). From 13,000 of our patients who underwent radioiodine scan for thyroid cancer, we have selected a few cases of 131I concentrating benign and malignant lesions for illustration. Results: Out of 13000 DTC patients who underwent whole body 131I scintigraphy in our department from Jan 2007 till Mar 2018, 25 patients revealed benign sites of 131I uptake. 61 % patients had residual thyroid tissue with or without associated nodal involvement. Remaining patients had distant metastases. Rare sites of functioning thyroid metastases and benign sites of I 131 uptake have been selected for illustration. Conclusion: Apart from the WBI (two-dimensional, planar) images, single-photon emission computed tomography-computed tomography (SPECT-CT) has been incremental in localizing benign lesions which greatly depends on their location. This pictorial review highlights the need to create an awareness to detect metastatic deposits of DTC at unexpected sites. Otherwise patients will need further investigation to rule out unsuspected sites of functioning distant metastases.

A Rare False-Positive Whole-Body Scan in a Patient With Differentiated Thyroid Cancer

Retrospective imaging study on the diagnosis of pathological false positive iodine-131 scans in patients with thyroid cancer.

Unusual I-131 Uptake in A Benign Mucinous Cystadenoma of the Ovary in A Patient with Papillary Thyroid Cancer

Application of dual-source computed tomography in the diagnosis of thyroid cancer and evaluation of biological behaviors

Nabothian Cyst Associated With High False-Positive Incidence Of Iodine-131 Uptake In Whole-Body Scans After Treatment For Differentiated Thyroid Cancer

False-Positive 131 I Uptake after Posttraumatic Scab in a Patient with Papillary Thyroid Carcinoma.

False-Positive <SUP>131</SUP>I Uptake After Posttraumatic Scab in a Patient With Papillary Thyroid Carcinoma

False-Positive 131I Uptake After Transareola Endoscopic Thyroidectomy in a Patient With Papillary Thyroid Carcinoma

Unusual Sites of Metastatic and Benign I 131 Uptake in Patients with Differentiated Thyroid Carcinoma

131 I Uptake in a Left Cerebral Infarct on Posttherapy Whole-Body Scan

An Unusual False-Positive Uptake of Radioiodine Caused by Breast Implants

Radioiodine whole body scan pitfalls in differentiated thyroid cancer

The Value of 131I SPECT/CT in Differentiating Indeterminate 131I Uptake on Planar Whole Body Scan

False-Positive Radioactive Iodine Uptake Caused by Cervical Myofascitis in a Patient with Differentiated Thyroid Carcinoma

131 I SPECT/CT: a One-Station Imaging Modality in the Management of Differentiated Thyroid Cancer

Abnormal 131I uptake in a benign serous ovarian cystadenoma mimicking bladder physiological uptake

18F-FDG SPECT/CT in the diagnosis of differentiated thyroid carcinoma with elevated thyroglobulin and negative iodine-131 scans.

Unusual Achalasia Presentation Detected on 131 I SPECT/CT in a Papillary Thyroid Carcinoma Patient

Unusual Achalasia Presentation Detected on 131I SPECT/CT in a Papillary Thyroid Carcinoma Patient

Uncommon Metastases from Differentiated Thyroid Carcinoma.

Diagnostic Performance of 18F-FDG PET/CT in Papillary Thyroid Carcinoma with Negative 131I-WBS at First Postablation, Negative Tg and Progressively Increased TgAb Level.